Plug and Play Upstream
Upstream Development The Right Way For You
You have a vision for your monoclonal antibody, and upstream development can be your major stepping stone to turn this potential into reality.
With our Plug & Play Upstream Development Service offering, you get exactly the service and expertise needed to go from DNA to clinic – the right way for you.
An Adaptive Approach to Deliver Against Your Timeline
A service designed around your needs - choose the path that’s right for you
Choose our proprietary CHOZN® platform, which allows for faster, simpler selection and scale-up of high-producing clones.
Right First Time
We help you find the right balance between speed and efficiency, so your clone demonstrates high quality and productivity early on to avoid delays in your clinical trials.
Leverage our innovative approach to mini-pools and confidently run process development and clone selection in parallel and save up to 10 weeks.
Run analytical development in parallel to your cell line development to get you progressing faster. Process transfer between our teams is seamless.
Exactly the Service Needed to Get You From DNA to Clinic
We bring you a wealth of in-house expertise in one plug & play service offer, exactly tailored to small biotechs, needing to balance cost and speed to clinic without sacrificing quality.
BioReliance® End-to-End Solutions
We are an adaptable CDMO partner for start-ups and small biotechs needing to develop and commercialize biologics. We do this by balancing speed, risk and cost through custom solutions, by leveraging our bioprocessing technologies and process development expertise, and by allowing our clients to transfer their
process and knowledge to their end point at any step of their drug development. To learn more, please visit BioReliance® End-to-End Solutions - Your CDMO Partner.